Donia Macartney-Coxson1, Kirsty Danielson2, Jane Clapham1, Miles C Benton1, Alice Johnston1, Angela Jones1, Odette Shaw3, Ronald D Hagan4, Eric P Hoffman5, Mark Hayes6, Jacquie Harper3, Michael A Langston4, Richard S Stubbs7. 1. Human Genomics, Institute of Environmental Science and Research (ESR), Wellington, New Zealand. 2. Department of Surgery and Anaesthesia, University of Otago Wellington, Wellington, New Zealand. 3. Arthritis and Inflammation Group, The Malaghan Institute of Medical Research, Victoria University of Wellington, Wellington, New Zealand. 4. Department of Electrical Engineering & Computer Science, University of Tennessee, Knoxville, Tennessee, USA. 5. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Binghamton University - SUNY, Binghamton, New York, USA. 6. The Wakefield Biomedical Research Unit, Wellington, New Zealand. 7. P3 Research, Wellington, New Zealand.
Abstract
OBJECTIVE: Adipose tissue plays a key role in obesity-related metabolic dysfunction. MicroRNA (miRNA) are gene regulatory molecules involved in intercellular and inter-organ communication. It was hypothesized that miRNA levels in adipose tissue would change after gastric bypass surgery and that this would provide insights into their role in obesity-induced metabolic dysregulation. METHODS: miRNA profiling (Affymetrix GeneChip miRNA 2.0 Array) of omental and subcutaneous adipose (n = 15 females) before and after gastric bypass surgery was performed. RESULTS: One omental and thirteen subcutaneous adipose miRNAs were significantly differentially expressed after gastric bypass, including downregulation of miR-223-3p and its antisense relative miR-223-5p in both adipose tissues. mRNA levels of miR-223-3p targets NLRP3 and GLUT4 were decreased and increased, respectively, following gastric bypass in both adipose tissues. Significantly more NLRP3 protein was observed in omental adipose after gastric bypass (P = 0.02). Significant hypomethlyation of NLRP3 and hypermethylation of miR-223 were observed in both adipose tissues after gastric bypass. In subcutaneous adipose, significant correlations were observed between both miR-223-3p and miR-223-5p and glucose and between NLRP3 mRNA and protein levels and blood lipids. CONCLUSIONS: This is the first report detailing genome-wide miRNA profiling of omental adipose before and after gastric bypass, and it further highlights the association of miR-223-3p and the NLRP3 inflammasome with obesity.
OBJECTIVE: Adipose tissue plays a key role in obesity-related metabolic dysfunction. MicroRNA (miRNA) are gene regulatory molecules involved in intercellular and inter-organ communication. It was hypothesized that miRNA levels in adipose tissue would change after gastric bypass surgery and that this would provide insights into their role in obesity-induced metabolic dysregulation. METHODS: miRNA profiling (Affymetrix GeneChip miRNA 2.0 Array) of omental and subcutaneous adipose (n = 15 females) before and after gastric bypass surgery was performed. RESULTS: One omental and thirteen subcutaneous adipose miRNAs were significantly differentially expressed after gastric bypass, including downregulation of miR-223-3p and its antisense relative miR-223-5p in both adipose tissues. mRNA levels of miR-223-3p targets NLRP3 and GLUT4 were decreased and increased, respectively, following gastric bypass in both adipose tissues. Significantly more NLRP3 protein was observed in omental adipose after gastric bypass (P = 0.02). Significant hypomethlyation of NLRP3 and hypermethylation of miR-223 were observed in both adipose tissues after gastric bypass. In subcutaneous adipose, significant correlations were observed between both miR-223-3p and miR-223-5p and glucose and between NLRP3 mRNA and protein levels and blood lipids. CONCLUSIONS: This is the first report detailing genome-wide miRNA profiling of omental adipose before and after gastric bypass, and it further highlights the association of miR-223-3p and the NLRP3 inflammasome with obesity.
Authors: Adriana Márquez-Quiñones; David M Mutch; Cyrille Debard; Ping Wang; Marion Combes; Balbine Roussel; Claus Holst; J Alfredo Martinez; Teodora Handjieva-Darlenska; Pavla Kalouskova; Susan Jebb; Dimitris Babalis; Andreas F H Pfeiffer; Thomas M Larsen; Arne Astrup; Wim H M Saris; Edwin Mariman; Karine Clément; Hubert Vidal; Dominique Langin; Nathalie Viguerie Journal: Am J Clin Nutr Date: 2010-08-25 Impact factor: 7.045
Authors: M Kolehmainen; T Salopuro; U S Schwab; J Kekäläinen; P Kallio; D E Laaksonen; L Pulkkinen; V I Lindi; K Sivenius; U Mager; N Siitonen; L Niskanen; H Gylling; R Rauramaa; M Uusitupa Journal: Int J Obes (Lond) Date: 2007-09-11 Impact factor: 5.095
Authors: Bolormaa Vandanmagsar; Yun-Hee Youm; Anthony Ravussin; Jose E Galgani; Krisztian Stadler; Randall L Mynatt; Eric Ravussin; Jacqueline M Stephens; Vishwa Deep Dixit Journal: Nat Med Date: 2011-01-09 Impact factor: 53.440
Authors: Miles C Benton; Alice Johnstone; David Eccles; Brennan Harmon; Mark T Hayes; Rod A Lea; Lyn Griffiths; Eric P Hoffman; Richard S Stubbs; Donia Macartney-Coxson Journal: Genome Biol Date: 2015-01-22 Impact factor: 13.583
Authors: Renata Viesti A Collares; Wilson Salgado; Daniela Pretti da Cunha Tirapelli; José Sebastião dos Santos Journal: PLoS One Date: 2014-04-01 Impact factor: 3.240
Authors: G Catanzaro; T Filardi; C Sabato; A Vacca; S Migliaccio; S Morano; E Ferretti Journal: J Endocrinol Invest Date: 2020-10-28 Impact factor: 4.256